Sridevi Rajeeve MD

Hematology•New York, NY

Hematologic Oncology

Assistant Attending L1, Myeloma & Cell Therapy Service, Memorial Sloan-Kettering Cancer Center, NY

Request appointment

530 East 74th StreetNew York, NY 10021
Book by Phone+1(775) 618-2456

Overview of Dr. Rajeeve

Physician-investigator with a clinical and research interest in plasma cell dyscrasias (Multiple Myeloma, Precursor states - MGUS/SMM, Amyloidosis, Waldenstrom's Macroglobulinemia, POEMS Syndrome etc.), cellular therapeutics, clinical trials, digital health technologies and healthcare delivery transformation.

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2020 - 2023
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2017 - 2020
Mahatma Gandhi UniversityClass of 2015, Bachelor of Medicine and Bachelor of Surgery (MBBS), Valedictorian

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NJ State Medical License 2023 - 2027
NY State Medical License 2023 - 2027
PA State Medical License 2025 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Educational Commission for Foreign Medical GraduatesECFMG

Awards, Honors, & Recognition

Domestic Scholar Award AIDS Malignancy Consortium
Young Investigator Award (YIA) American Society of Clinical Oncology (ASCO), 2022
HONORS Award and Grant American Society of Hematology (ASH)

Clinical Trials

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma Start of enrollment: 2024 Sep 03
ACTIVE_NOT_RECRUITING
PHASE1
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma Start of enrollment: 2023 Dec 05
RECRUITING
PHASE1, PHASE2
A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma Start of enrollment: 2024 Aug 20
ACTIVE_NOT_RECRUITING
PHASE2

Publications & Presentations

PubMed

Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma.
Alexandra D Dreyfuss, Joachim Yahalom, Sridevi Rajeeve, Alexander M Lesokhin, Gunjan L Shah
Blood Cancer Journal. 2026-08-19
Robust CD4CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.
Eric M Jurgens, Sneha Mitra, Kevin Herrera, David Nemirovsky, Brenden Bready
Science Translational Medicine. 2026-07-29
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.
Kevin Charles Miller, Teng Fei, Ruben J Faustino Ramos, Francesca Castro, Ana Gradissimo
Clinical Cancer Research. 2026-07-20

Abstracts/Posters

Myelodysplastic Syndromes: Trends in Mortality, Costs of Hospitalizations, Length of Stay and Rate of Complications
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Acute Myeloid Leukemia and Cirrhosis: Trends in Utilization of Induction Chemotherapy, Rate of Hospitalizations and Mortality
Sridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019